Evaluation of slow release mucoadhesive paste of” MUCODENTOL in oral vestibule on symptoms of COVID-19 disease in hospital staff

Early Phase 1

• Conditions: COVID-19.; COVID-19, PREVENTION; U07.1

• Registration Number: IRCT20090304001739N3
• Lead Sponsor: Khoram-Abad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 September 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 1600

Inclusion Criteria

Mental and physical ability to use this drug for three weeks- Lack of sensitivity to drugs and similar drugs- staffs working in the ICU / Emergency / Hospital wards of the Corona Center for Nomadic Martyrs- Men and women - Be able to communicate for a telephone interview

Exclusion Criteria

-Lack of cooperation- Impossibility of telephone interviews- Do not use the drug regularly- - Drug sensitivity- Pregnancy and lactation

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Detection and severity if covid 19 disease. Timepoint: at the end of the first - second - third week of participation in study. Method of measurement: Examination by a doctor.

Secondary Outcome Measures

Name	Time	Method
Respiratory-general symptoms. Timepoint: weekly. Method of measurement: Mild - moderate - severe.;Fever. Timepoint: weekly. Method of measurement: Thermometer.